NYSE · Medical - Instruments & Supplies

AptarGroup, Inc. (ATR) Stock

$126.55 -1.21% NYSE: ATR Healthcare

Valuation

MetricValue
Price$126.55
Market Cap$8.05B
P/E Ratio21.41
P/B Ratio2.91
P/S Ratio1.95
EPS (TTM)$5.88
52-Week High$146.91
52-Week Low$103.23
Dividend Yield1.60%

Financials & Margins

MetricValue
ROE13.52%
ROA7.06%
ROCE12.17%
Gross Margin13.56%
Operating Margin13.56%
Net Margin9.22%
Debt/Equity0.54
Current Ratio1.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.2B$3.3B$3.5B$3.6B$3.8B
Operating Profit$347.0M$379.0M$404.0M$496.0M$512.0M
Net Profit$244.0M$239.0M$284.0M$375.0M$393.0M
EPS$3.60$3.59$4.25$5.53$5.88
Op Margin10.8%11.4%11.6%13.9%13.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$4.1B$4.2B$4.5B$4.4B$5.3B
Total Liabilities$2.2B$2.1B$2.1B$1.9B$2.5B
Cash$123.0M$142.0M$224.0M$224.0M$402.0M
Borrowings$1.2B$1.2B$1.2B$1.1B$1.5B

Latest News

ATR: Raising target price to $135.00 Argus Research · Jul 15, 2026 Packaging, Forest Products Face Lackluster Demand, Weak Volumes, BofA Says MT Newswires · Jul 14, 2026 BofA Upgrades AptarGroup to Buy From Neutral, Price Target is $173 MT Newswires · Jul 14, 2026 Aptar Named Among Top 100 of America’s Best Companies by TIME Business Wire · Jul 13, 2026 Aptar Releases 2025 Corporate Sustainability Report Business Wire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$363.0M$479.0M$575.0M$643.0M$570.0M
Investing Cash Flow$-765.0M$-611.0M$-643.0M$-691.0M$-601.0M
Financing Cash Flow$-20.0M$-68.0M$-16.0M$-14.0M$-365.0M
Net Cash Flow$-182.0M$20.0M$81.0M$0$178.0M
Free Cash Flow$56.0M$163.0M$257.0M$349.0M$300.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-4.08
EV / EBITDA10.81
FCF Yield4.06%
Quick Ratio1.10
Interest Coverage7.66
Return 1Y-7.44%
Return 3Y-1.10%
Return 5Y3.35%

Ownership

Insiders Held0.88%
Institutions Held97.12%
Institutions Float Held97.98%
Institutional HolderSharesReport Date
Blackrock Inc.6,083,5182026-03-31
State Farm Mutual Automobile Insurance Co4,744,5642026-03-31
Vanguard Portfolio Management LLC3,767,7722026-03-31
Morgan Stanley3,375,7962026-03-31
Vanguard Capital Management LLC2,885,2972026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMCRAmcor plc $46.11 -0.37% 17.51 $21.32B 6.21%
SLGNSilgan Holdings Inc. $39.30 -1.16% 13.72 $4.15B 2.40%
SONSonoco Products Company $50.12 -0.30% 7.52 $4.96B 4.43%
STVNStevanato Group S.p.A. $19.49 -0.05% 37.38 $5.32B 0.30%
TRSTriMas Corporation $39.60 -0.75% 1.60 $1.42B 0.41%

About AptarGroup, Inc.

AptarGroup, Inc. is led by CEO Stephan Tanda, employs 14,000 people, headquartered in Crystal Lake, US, publicly traded since 1993.

AptarGroup, Inc. (ATR) stock trades at $126.55 with a market capitalization of $8.05B. The stock is valued at a price-to-earnings (P/E) ratio of 21.41, price-to-book of 2.91, price-to-sales of 1.95. Over the past 52 weeks the stock has ranged between $103.23 and $146.91, and currently trades 13.9% below its 52-week high. It pays a dividend yielding 1.60%.

On profitability, AptarGroup, Inc. generates a return on equity (ROE) of 13.52%, return on capital employed of 12.17%, an operating margin of 13.56%, a net profit margin of 9.22%.

AptarGroup, Inc. by the numbers, 2016–2025

Between 2016 and 2025 AptarGroup, Inc. reported revenue of $2.3B rising to $3.8B, a change of +62.0% across 10 years. Compounded, revenue has grown 5.2% a year over five years, 4.4% over three, 5.4% over the last twelve months. Net profit rose to $393.0M.

Operating margin went from 13.3% in 2016 to 13.6% in 2025, essentially unchanged. The most recent net margin is 9.22%. On a trailing twelve-month basis to Jun '26, revenue is $3.9B and net profit $363.0M.

Borrowings rose from $948.0M to $1.5B, cash from operations was $570.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 13.3% over five years, and was 14.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

AptarGroup, Inc. (ATR) — frequently asked questions

What is AptarGroup, Inc. (ATR) stock price today?

AptarGroup, Inc. (ATR) is currently trading at $126.55, down 1.21% today.

What is ATR P/E ratio?

AptarGroup, Inc.'s P/E ratio is 21.41. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is ATR return on equity (ROE)?

AptarGroup, Inc.'s return on equity (ROE) is 13.52%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.

What is AptarGroup, Inc.'s market cap?

AptarGroup, Inc. has a market capitalization of $8.05B.

Does ATR pay a dividend?

Yes. AptarGroup, Inc. currently yields 1.60%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does ATR carry?

AptarGroup, Inc. has a debt-to-equity ratio of 0.54. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is ATR's profit margin?

AptarGroup, Inc. reports a net profit margin of 9.22% — the share of revenue left after every cost, including tax and interest.

What sector is ATR in?

AptarGroup, Inc. is classified under Healthcare, in the Medical - Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is ATR listed on?

AptarGroup, Inc. trades on NYSE under the ticker ATR.

What is ATR's 52-week range?

Over the last year AptarGroup, Inc. has traded between $103.23 and $146.91.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens ATR currently matches

On the figures above, AptarGroup, Inc. passes the filters for 7 of our ready-made screens, among them Dividend Stocks, Healthcare Stocks To Buy, Mid Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksHealthcare Stocks To BuyMid Cap StocksNYSE Listed StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.